Joseph Fredi
-
Trial to test aortic valve technique in lower-risk patients
In 2011, doctors at the Vanderbilt Heart and Vascular Institute performed the state’s first transcatheter valve-replacement (TAVR) procedure for high-risk patients suffering from aortic stenosis, the most common valvular heart disease in the United States. Read MoreOct 27, 2016
-
Vanderbilt Heart to participate in CoreValve clinical trial
Vanderbilt Heart will soon begin testing the safety of a novel, non-surgical approach to treating aortic stenosis, a common heart problem caused by an abnormal narrowing of the heart's aortic valve. Read MoreApr 18, 2011